Medicines and driving: evaluation of training and software support for patient counselling by pharmacists

Legrand, Sara‐Ann; Boets, Sofie; Meesmann, Uta; Verstraete, Alain G.

doi:10.1007/s11096-012-9658-7

Cited by 18 publications

(30 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The 22 studies comprised 10 RCTs [54][55][56][57][58][59][60][61][62][63], 3 NRCTs [64][65][66], 1 CBA trial [67] and 8 quasi-experimental or observational studies [68][69][70][71][72][73][74][75] (Tables 1 and 2). The studies were conducted in Australia (n = 8) [54-56, 60, 64, 65, 68, 69], the USA (n = 4) [57][58][59]73], the UK (n = 3) [62,63,75], the Netherlands (n = 2) [61,72], Belgium (n = 1) [67], Canada, (n = 1) [71], Finland (n = 1) [74], Germany (n = 1) [70] and Switzerland (n = 1) [66].…”

Section: Study Characteristics Including Risk Of Bias Assessmentsmentioning

confidence: 99%

“…The studies were conducted in Australia (n = 8) [54-56, 60, 64, 65, 68, 69], the USA (n = 4) [57][58][59]73], the UK (n = 3) [62,63,75], the Netherlands (n = 2) [61,72], Belgium (n = 1) [67], Canada, (n = 1) [71], Finland (n = 1) [74], Germany (n = 1) [70] and Switzerland (n = 1) [66]. The time frame for intervention-duration ranged from 1 day to 2 years.…”

Section: Study Characteristics Including Risk Of Bias Assessmentsmentioning

confidence: 99%

“…They involved chronic disease states [57,60,65,71,75], guidelines for the supply of particular classes of medications [55,56,59,61,64,66,[68][69][70]72], community pharmacy's role in preventative health [58,67,73] and guidelines for appropriate pharmacy practice [63,74]. The variation did not allow for any conclusions to be made about the effectiveness of implementation based on guideline characteristics.…”

Section: Implementation Strategies and Their Effectivenessmentioning

confidence: 99%

“…Implementation activities were targeted to community pharmacy, and in particular to pharmacists in 20 studies [54][55][56][57][58][59][60][61][62][65][66][67][68][69][70][71][72][73][74][75] and pharmacy support staff in 11 studies [56, 58, 61-64, 66, 68, 69, 72, 75]. In two studies, implementation activities were directed exclusively to pharmacy support staff, while three studies involved implementation activities to other health professionals and/or patients as well as community pharmacy staff [58,65,70].…”

Section: Implementation Strategies and Their Effectivenessmentioning

confidence: 99%

See 3 more Smart Citations

Effectiveness of implementation strategies for clinical guidelines to community pharmacy: A systematic review

Watkins

Wood

Clifford

et al. 2016

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

Section: Study Characteristics Including Risk Of Bias Assessmentsmentioning

confidence: 99%

Section: Study Characteristics Including Risk Of Bias Assessmentsmentioning

confidence: 99%

Section: Implementation Strategies and Their Effectivenessmentioning

confidence: 99%

Section: Implementation Strategies and Their Effectivenessmentioning

confidence: 99%

See 2 more Smart Citations

Effectiveness of implementation strategies for clinical guidelines to community pharmacy: A systematic review

Watkins

Wood

Clifford

et al. 2016

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

“…En otros países como el Reino Unido (47), está prohibida la conducción de vehículos con la presencia de drogas de abuso y algunos medicamentos que afectan a la capacidad de conducir de forma segura como son la anfetamina, varias benzodiacepinas, metadona y morfina. (50).…”

Section: Figuraunclassified

Estudio de utilización de medicamentos con pictograma “Medicamentos y Conducción”: prevalencia de consumo en la población de Castilla y León

Abejón¹

View full text Add to dashboard Cite

El peldaño de una escalera nunca fue diseñado para descansar, sino para sostener el pie de un hombre lo suficiente para permitirle poner el otro un poco más arriba. Thomas Henry Huxley (1825-1895) Zoólogo inglés AgradecimientosQuiero expresar mi agradecimiento a todas las personas que han colaborado de alguna forma en la realización de esta Tesis Doctoral.Al Profesor F. Javier Álvarez González, por confiar en mí y facilitarme la oportunidad de realizar este proyecto. Por haberme brindado su apoyo, su experiencia, su tiempo y su consejo.Al Dr. Francisco Herrera Gómez, por su incalculable apoyo y por todo el tiempo que ha dedicado en la planificación y desarrollo de este proyecto.A los coautores de los artículos por haberme permitido presentarlos en este compendio, en especial a Paloma Criado Espegel, con la que he compartido muchas horas de trabajo en la

show abstract

Driving under the influence of drugs

Marillier

Verstraete

2019

WIREs Forensic Science

Self Cite

View full text Add to dashboard Cite

Driving is a very complex task, requiring the cooperation of several different cognitive and psychomotor functions at once. Approximately 2% of the drivers drive under the influence of drugs, sometimes more (20%) and more at specific times (weekend nights). Population surveys show that self‐reported driving after using psychoactive drugs (mostly cannabis) varies between 3.8 and 29.9%. In injured and fatally injured drivers, about 20–40% test positive for drugs. The risk of a crash is almost doubled after cannabis use, increased about seven times after amphetamine use. For the other drugs, the risk falls between these extremes. Amphetamines are estimated to cause half of the fatalities due to driving under the infuence of drugs (DUID). Medicinal drugs, taken according to prescription, only increase crash risk by 20–40%. In France 4% and 3% of the accidents could be prevented if no one drove after taking cannabis and impairing therapeutic drugs, respectively. Three types of DUID legislation exist: “impairment” legislation, “per se” legislation and the “two‐tier” approach that combines both. In impairment legislation, the prosecution must demonstrate that the driver was impaired or “under the influence.” A “per se” law prohibits driving if drugs are present in blood, serum, plasma, or oral fluid (OF) above a certain threshold concentration. OF is commonly used for roadside drug screening of drivers, and increasingly for confirmation as well. Recently developed methods for confirmation analysis, either on blood or on OF, use liquid chromatography (tandem) mass spectrometry (LC–MS[MS]) to test for dozens of drugs on a small sample volume. This article is categorized under: Toxicology > Drug‐Impaired Driving Toxicology > Drug Analysis

show abstract

Medicines and driving: evaluation of training and software support for patient counselling by pharmacists

Cited by 18 publications

References 25 publications

Effectiveness of implementation strategies for clinical guidelines to community pharmacy: A systematic review

Effectiveness of implementation strategies for clinical guidelines to community pharmacy: A systematic review

Estudio de utilización de medicamentos con pictograma “Medicamentos y Conducción”: prevalencia de consumo en la población de Castilla y León

Driving under the influence of drugs

Contact Info

Product

Resources

About